These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25797522)

  • 1. Intramyocardial bone marrow mononuclear cell transplantation in ischemic heart failure: Long-term follow-up.
    Lehtinen M; Pätilä T; Kankuri E; Lauerma K; Sinisalo J; Laine M; Kupari M; Vento A; Harjula A;
    J Heart Lung Transplant; 2015 Jul; 34(7):899-905. PubMed ID: 25797522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass.
    Pätilä T; Lehtinen M; Vento A; Schildt J; Sinisalo J; Laine M; Hämmäinen P; Nihtinen A; Alitalo R; Nikkinen P; Ahonen A; Holmström M; Lauerma K; Pöyhiä R; Kupari M; Kankuri E; Harjula A
    J Heart Lung Transplant; 2014 Jun; 33(6):567-74. PubMed ID: 24656645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
    Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
    Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcome of Intra-Myocardial Injection of Autologous Bone Marrow Mononuclear Cells Combined with Isolated Coronary Artery Bypass Grafting for Patients with Chronic Ischemic Heart Failure.
    Wang R; Zhang L; Wang Y; Gong Z; Xiao C; Wu Y; Ren C; Cheng N; Gao C
    Heart Surg Forum; 2016 Jun; 19(3):E131-8. PubMed ID: 27355149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction.
    Delewi R; van der Laan AM; Robbers LF; Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; Tio RA; Waltenberger J; Ten Berg JM; Doevendans PA; Gehlmann HR; van Rossum AC; Piek JJ; Zijlstra F;
    Heart; 2015 Mar; 101(5):363-8. PubMed ID: 25294647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized, double-blinded trial of bone marrow cell transplantation combined with coronary surgery - perioperative safety study.
    Lehtinen M; Pätilä T; Vento A; Kankuri E; Suojaranta-Ylinen R; Pöyhiä R; Harjula A;
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):990-6. PubMed ID: 25142068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.
    Perin EC; Dohmann HF; Borojevic R; Silva SA; Sousa AL; Mesquita CT; Rossi MI; Carvalho AC; Dutra HS; Dohmann HJ; Silva GV; Belém L; Vivacqua R; Rangel FO; Esporcatte R; Geng YJ; Vaughn WK; Assad JA; Mesquita ET; Willerson JT
    Circulation; 2003 May; 107(18):2294-302. PubMed ID: 12707230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
    Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up].
    Gao LR; Wang ZG; Tian HT; Zhu ZM; Fei YX; Xu HT; Chen Y; Zhu JR; He S; Zhang NK; Ding QA; Yang Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):685-9. PubMed ID: 17553306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional recovery of patients with ischemic cardiomyopathy treated with coronary artery bypass surgery and concomitant intramyocardial bone marrow mononuclear cell implantation--a long-term follow-up study.
    Trifunović Z; Obradović S; Balint B; Ilić R; Vukić Z; Šišić M; Kostić J; Rusović S; Dobrić M; Ostojić G
    Vojnosanit Pregl; 2015 Mar; 72(3):225-32. PubMed ID: 25958473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study.
    Pokushalov E; Romanov A; Chernyavsky A; Larionov P; Terekhov I; Artyomenko S; Poveshenko O; Kliver E; Shirokova N; Karaskov A; Dib N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):160-8. PubMed ID: 20560030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study.
    Robbers LF; Nijveldt R; Beek AM; Hirsch A; van der Laan AM; Delewi R; van der Vleuten PA; Tio RA; Tijssen JG; Hofman MB; Piek JJ; Zijlstra F; van Rossum AC;
    Radiology; 2014 Jul; 272(1):113-22. PubMed ID: 24617731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction.
    Lu M; Liu S; Zheng Z; Yin G; Song L; Chen H; Chen X; Chen Q; Jiang S; Tian L; He Z; Hu S; Zhao S
    Int J Cardiol; 2013 Oct; 168(3):2221-7. PubMed ID: 23478196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.
    Yoo KJ; Kim HO; Kwak YL; Kang SM; Jang YS; Lim SH; Hwang KC; Cho SW; Yang YS; Li RK; Kim BS
    Can J Surg; 2008 Aug; 51(4):269-75. PubMed ID: 18815649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
    Stamm C; Kleine HD; Choi YH; Dunkelmann S; Lauffs JA; Lorenzen B; David A; Liebold A; Nienaber C; Zurakowski D; Freund M; Steinhoff G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):717-25. PubMed ID: 17320570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy.
    Akar AR; Durdu S; Arat M; Kilickap M; Kucuk NO; Arslan O; Kuzu I; Ozyurda U
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):633-43. PubMed ID: 19524451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
    JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
    Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
    Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined use of transmyocardial laser revascularisation and intramyocardial injection of bone-marrow derived stem cells in patients with end-stage coronary artery disease: one year follow-up.
    Konstanty-Kalandyk J; Piątek J; Miszalski-Jamka T; Rudziński P; Walter Z; Bartuś K; Urbańczyk-Zawadzka M; Sadowski J
    Kardiol Pol; 2013; 71(5):485-92. PubMed ID: 23788089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.